Tofflon Science and Technology Group Past Earnings Performance
Past criteria checks 1/6
Tofflon Science and Technology Group has been growing earnings at an average annual rate of 12.7%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 19.4% per year. Tofflon Science and Technology Group's return on equity is 2.2%, and it has net margins of 3.5%.
Key information
12.7%
Earnings growth rate
10.1%
EPS growth rate
| Medical Equipment Industry Growth | 16.0% |
| Revenue growth rate | 19.4% |
| Return on equity | 2.2% |
| Net Margin | 3.5% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Tofflon Science and Technology Group's (SZSE:300171) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 04
Weak Statutory Earnings May Not Tell The Whole Story For Tofflon Science and Technology Group (SZSE:300171)
May 06Recent updates
Tofflon Science and Technology Group's (SZSE:300171) Weak Earnings May Only Reveal A Part Of The Whole Picture
Nov 04What You Can Learn From Tofflon Science and Technology Group Co., Ltd.'s (SZSE:300171) P/E
Sep 26Tofflon Science and Technology Group's (SZSE:300171) Returns On Capital Are Heading Higher
Aug 05Tofflon Science and Technology Group (SZSE:300171) Is Reducing Its Dividend To CN¥0.2392
Jul 12It's A Story Of Risk Vs Reward With Tofflon Science and Technology Group Co., Ltd. (SZSE:300171)
May 27Weak Statutory Earnings May Not Tell The Whole Story For Tofflon Science and Technology Group (SZSE:300171)
May 06Tofflon Science and Technology Group (SZSE:300171) Is Doing The Right Things To Multiply Its Share Price
Mar 19Revenue & Expenses Breakdown
How Tofflon Science and Technology Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 4,806 | 170 | 837 | 357 |
| 30 Jun 24 | 4,982 | 288 | 815 | 369 |
| 31 Mar 24 | 5,328 | 434 | 903 | 374 |
| 31 Dec 23 | 5,642 | 600 | 903 | 380 |
| 30 Sep 23 | 5,977 | 826 | 947 | 370 |
| 30 Jun 23 | 5,993 | 870 | 957 | 346 |
| 31 Mar 23 | 5,655 | 866 | 880 | 329 |
| 01 Jan 23 | 5,469 | 847 | 856 | 333 |
| 30 Sep 22 | 5,127 | 874 | 792 | 351 |
| 30 Jun 22 | 4,810 | 890 | 751 | 337 |
| 31 Mar 22 | 4,713 | 929 | 699 | 329 |
| 01 Jan 22 | 4,192 | 828 | 665 | 285 |
| 30 Sep 21 | 3,726 | 733 | 622 | 227 |
| 30 Jun 21 | 3,328 | 632 | 551 | 191 |
| 31 Mar 21 | 2,921 | 527 | 490 | 164 |
| 31 Dec 20 | 2,708 | 463 | 467 | 156 |
| 30 Sep 20 | 2,658 | 373 | 413 | 139 |
| 30 Jun 20 | 2,527 | 280 | 424 | 129 |
| 31 Mar 20 | 2,329 | 177 | 447 | 128 |
| 31 Dec 19 | 2,264 | 146 | 446 | 119 |
| 30 Sep 19 | 2,031 | 65 | 450 | 97 |
| 30 Jun 19 | 1,926 | 66 | 414 | 112 |
| 31 Mar 19 | 1,894 | 65 | 432 | 99 |
| 31 Dec 18 | 1,917 | 70 | 414 | 98 |
| 30 Sep 18 | 1,886 | 78 | 419 | 102 |
| 30 Jun 18 | 1,856 | 84 | 346 | 154 |
| 31 Mar 18 | 1,735 | 93 | 338 | 134 |
| 31 Dec 17 | 1,725 | 123 | 333 | 113 |
| 30 Sep 17 | 1,535 | 160 | 313 | 87 |
| 30 Jun 17 | 1,387 | 174 | 379 | 0 |
| 31 Mar 17 | 1,355 | 200 | 350 | 0 |
| 31 Dec 16 | 1,328 | 235 | 343 | 0 |
| 30 Sep 16 | 1,433 | 297 | 347 | 0 |
| 30 Jun 16 | 1,491 | 331 | 348 | 0 |
| 31 Mar 16 | 1,591 | 372 | 339 | 0 |
| 31 Dec 15 | 1,556 | 387 | 328 | 0 |
| 30 Sep 15 | 1,449 | 391 | 308 | 0 |
| 30 Jun 15 | 1,415 | 376 | 298 | 0 |
| 31 Mar 15 | 1,349 | 369 | 285 | 0 |
| 31 Dec 14 | 1,259 | 335 | 268 | 0 |
| 30 Sep 14 | 1,153 | 278 | 258 | 0 |
| 30 Jun 14 | 1,106 | 281 | 246 | 0 |
| 31 Mar 14 | 1,065 | 271 | 225 | 0 |
| 31 Dec 13 | 1,021 | 266 | 219 | 0 |
Quality Earnings: 300171 has a large one-off gain of CN¥74.1M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 300171's current net profit margins (3.5%) are lower than last year (13.8%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 300171's earnings have grown by 12.7% per year over the past 5 years.
Accelerating Growth: 300171's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 300171 had negative earnings growth (-79.5%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).
Return on Equity
High ROE: 300171's Return on Equity (2.2%) is considered low.